Insider trades
Stephen K. Brannan, Director of Serina Therapeutics SER, has filed 0 purchases and 29 sales on the open market. The latest trade was on 06/17.
Stephen K. Brannan
Director
- Company
- Serina Therapeutics SER
- First filing
- 23/02/13
- Trades
- 91 trades
- Buys / sales
- 0 / 29
- 12-month net buying
- No record
- Last trade
- 06/17
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 24/03/08 | 24/03/11 | 5,000 sh2 trades | $318.34avg. | $1,591,713 | −10.5% | |
| Open-market sale10b5-1 plan | 24/02/08 | 24/02/12 | 5,000 sh2 trades | $316.13avg. | $1,580,667.18 | −10.8% | |
| Open-market sale10b5-1 plan | 24/01/08 | 24/01/09 | 15,000 sh | $316.81 | $4,752,150 | −28.0% | |
| Open-market sale10b5-1 plan | 23/12/08 | 23/12/12 | 10,000 sh5 trades | $202.37avg. | $2,023,675.51 | −21.7% | |
| Open-market sale10b5-1 plan | 23/11/08 | 23/11/13 | 5,000 sh5 trades | $177.85avg. | $889,259.5 | −12.9% | |
| Open-market sale10b5-1 plan | 23/10/09 | 23/10/10 | 5,000 sh2 trades | $173.24avg. | $866,212.64 | −13.8% | |
| Open-market sale10b5-1 plan | 23/09/08 | 23/09/11 | 5,000 sh4 trades | $184.04avg. | $920,202.84 | −14.9% | |
| Open-market sale10b5-1 plan | 23/08/08 | 23/08/10 | 5,000 sh3 trades | $180.40avg. | $902,009.5 | −16.1% | |
| Open-market sale10b5-1 plan | 23/04/10 | 23/04/12 | 5,000 sh | $176.88 | $884,400 | −17.5% | |
| Open-market sale | 23/03/09 | 23/03/09 | 5,000 sh | $189.51 | $947,550 | −17.5% | |
| Open-market sale | 23/02/09 | 23/02/13 | 5,000 sh | $192.37 | $961,850 | −25.0% | |
| Open-market sale | 23/01/09 | 23/01/09 | 5,000 sh2 trades | $197.52avg. | $987,600 | −25.0% |